Beacon Biosignals: Valuation, Funding & Investors
Beacon Biosignals is unlocking the power of brain data to advance human health. The company combines FDA-cleared wearable EEG technology with advanced AI to capture and analyze real-world neural data, enabling breakthroughs across neurology, psychiatry, and sleep medicine. The Beacon Platform provides clinicians and biopharma partners with objective measures of brain function that accelerate research, improve diagnostics, and guide new treatments.
Leadership & Board
- Current Number of Employees
- 191
- Current LinkedIn Followers
- 16,740
Latest Estimated Valuation
- Total Amount Raised
- $86M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $86M
- Latest Funding Round
- Series B
Company Momentum Positive
Beacon Biosignals LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Beacon Biosignals had 191 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Beacon Biosignals had 16,740 followers as of October 26, 2026. The number of followers increased by 264 (1.60%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 13, 2025 | Series B | $86.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| General Catalyst | Series B |
| Catalio Capital Management | Series B |
| Logos Capital | Series B |
| Nexus NeuroTech Ventures | Series B |
| S32 | Series B |
| Casdin Capital | Series B |
| Indicator Ventures | Series B |
| Takeda | Series B |
Similar Companies
A snapshot of private companies similar to Beacon Biosignals, helping you discover and navigate related company profiles.
Related News and Analysis
